NEW YORK (GenomeWeb) – Agilent Technologies is preparing to launch a new product in its CRISPR/Cas9-related SureGuide portfolio, and it's looking for partners to help evaluate it and provide feedback.

Last week, Agilent announced an early-access program for its SureGuide pooled guide RNA (gRNA) libraries for genetic screening. Though it has been building a list of partners since December, the firm has no limit on the number of projects it can take on under the program.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.